Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1)

Journal of Allergy and Clinical Immunology Global(2025)10.1016/j.jacig.2025.100503Source: DataRank Database

Refractory marginal zone lymphoma uncovers activated phosphoinositide 3-kinase delta syndrome type 1 (APDS1) is a research paper published in Journal of Allergy and Clinical Immunology Global (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.00)OA: goldTopics (15)IDs (PubMed, PMC, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Matthew Farley,Holly Miller,Charlotte Cunningham‐Rundles ORCID,Catherine Freeman ORCID,Jacqueline D. Squire ORCID

Live enrichment

PubMed:40583960 PMC:PMC12205638 OpenAlex:https://openalex.org/W4410733914

National Cancer Institute Division of Cancer Prevention

Grant: U01CA271410

Mayo Clinic Hematological Malignancies Program

Paula and Rodger Riney Foundation

National Institutes of Health

Mayo Clinic

National Cancer Institute

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jacig.2025.100503

publisherhttps://doi.org/10.1016/j.jacig.2025.100503

publisherhttps://api.elsevier.com/content/article/PII:S2772829325001043?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2772829325001043?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40583960

Fields of Study

Immunodeficiency and Autoimmune DisordersChronic Lymphocytic Leukemia ResearchBlood disorders and treatments

Keywords

LymphomaMarginal zoneCancer researchGeologyBiologyImmunologyB cellGenomicsCase ReportPrimary ImmunodeficiencyMarginal Zone LymphomaActivated Phosphoinositide 3-Kinase Delta Syndrome